The Philippines national health authority recently rejected a bid to include the antiparasitic medicine Ivermectin for recommended use against COVID-19. Recently, the Department of Health decided there wasn’t enough evidence to make that recommendation. A common drug used for various parasites mostly found in the tropics but also elsewhere, the drug is also used in some nations and regions. For example, in India certain states, such as Uttar Pradesh, with 205 million residents, has accepted the drug as a compelling early onset treatment targeting COVID-19. In Brazil, some states and local public health departments hand out home treatment kits while at least for a while in nations, such as Peru, the drug was accepted by the national authority. TrialSite produced a documentary on this phenomena which can be watched here. A concern at least in some South American nations has been local abuse of the drug via self-medication and lack of appropriate oversight. Now the Philippines has opted for more evidence before they can greenlight such a recommendation for approval.
COVID-19 in the Philippines
As reported recently by ABS-CBN News in the Philippines, Kristine Sabillo writes that...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).